Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deblina Raychaudhuri

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Research (Washington, D.C.)|January 26, 2026
Spatiotemporal Regulation of Ligand Trafficking and TLR9 Activation by PIEZO1 in Human Plasmacytoid Dendritic CellsShrestha Pattanayak, Deblina Raychaudhuri, Purbita Bandopadhyay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2019
Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus EndophenotypeOindrila Rahaman, Roopkatha Bhattacharya, Chinky Shiu Chen Liu, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2022
Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19Deblina Raychaudhuri, Purbita Bandopadhyay, Ranit D'Rozario, et al.
Frontiers in Immunology|August 24, 2019
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic CellsDeblina Raychaudhuri, Roopkatha Bhattacharya, Bishnu Prasad Sinha, et al.
Viruses|February 28, 2023
Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19Ranit D'Rozario, Deblina Raychaudhuri, Purbita Bandopadhyay, et al.
Cell|April 14, 2023
Immune checkpoint therapy-current perspectives and future directionsPadmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Nature Communications|January 7, 2026
Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancerPratishtha Singh, Ranit D'Rozario, Bidisha Chakraborty, et al.
Diabetes|August 27, 2016
Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel MetaflammationAmrit Raj Ghosh, Roopkatha Bhattacharya, Shamik Bhattacharya, et al.
Nature Cancer|August 31, 2023
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockadeSangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, et al.
Frontiers in Immunology|November 15, 2021
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19Jafar Sarif, Deblina Raychaudhuri, Ranit D'Rozario, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Research (Washington, D.C.)|January 26, 2026
Spatiotemporal Regulation of Ligand Trafficking and TLR9 Activation by PIEZO1 in Human Plasmacytoid Dendritic CellsShrestha Pattanayak, Deblina Raychaudhuri, Purbita Bandopadhyay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 8, 2019
Cutting Edge: Dysregulated Endocannabinoid-Rheostat for Plasmacytoid Dendritic Cell Activation in a Systemic Lupus EndophenotypeOindrila Rahaman, Roopkatha Bhattacharya, Chinky Shiu Chen Liu, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|September 19, 2022
Clinical Trial Subgroup Analyses to Investigate Clinical and Immunological Outcomes of Convalescent Plasma Therapy in Severe COVID-19Deblina Raychaudhuri, Purbita Bandopadhyay, Ranit D'Rozario, et al.
Frontiers in Immunology|August 24, 2019
Lactate Induces Pro-tumor Reprogramming in Intratumoral Plasmacytoid Dendritic CellsDeblina Raychaudhuri, Roopkatha Bhattacharya, Bishnu Prasad Sinha, et al.
Viruses|February 28, 2023
Circulating Interleukin-8 Dynamics Parallels Disease Course and Is Linked to Clinical Outcomes in Severe COVID-19Ranit D'Rozario, Deblina Raychaudhuri, Purbita Bandopadhyay, et al.
Cell|April 14, 2023
Immune checkpoint therapy-current perspectives and future directionsPadmanee Sharma, Sangeeta Goswami, Deblina Raychaudhuri, et al.
Nature Communications|January 7, 2026
Loss of KDM6A-mediated genomic instability and metabolic reprogramming regulates response to therapeutic perturbations in bladder cancerPratishtha Singh, Ranit D'Rozario, Bidisha Chakraborty, et al.
Diabetes|August 27, 2016
Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel MetaflammationAmrit Raj Ghosh, Roopkatha Bhattacharya, Shamik Bhattacharya, et al.
Nature Cancer|August 31, 2023
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockadeSangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, et al.
Frontiers in Immunology|November 15, 2021
Plasma Gradient of Soluble Urokinase-Type Plasminogen Activator Receptor Is Linked to Pathogenic Plasma Proteome and Immune Transcriptome and Stratifies Outcomes in Severe COVID-19Jafar Sarif, Deblina Raychaudhuri, Ranit D'Rozario, et al.
Pageof 3